Upgrade to SI Premium - Free Trial

TransMedics Group (TMDX) PT Lowered to $75 at Stifel

May 26, 2026 7:39 AM
Stifel analyst Thomas Stephan lowered the price target on TransMedics Group (NASDAQ: TMDX) to $75.00 (from $85.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change